<DOC>
	<DOCNO>NCT00003489</DOCNO>
	<brief_summary>RATIONALE : Antineoplastons naturally-occurring substance may also make laboratory . Antineoplastons may inhibit growth cancer cell . PURPOSE : This phase II trial study effectiveness antineoplaston therapy treat patient advanced head neck cancer .</brief_summary>
	<brief_title>Antineoplaston Therapy Treating Patients With Advanced Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Provide treatment antineoplastons A10 AS2-1 patient incurable cancer head neck . - Describe response , tolerance , side effect regimen patient . OUTLINE : This open-label study . Patients receive gradually escalate dos antineoplaston A10 antineoplaston AS2-1 intravenous injection six time per day maximum tolerate dose reach . Treatment continue least 2 month absence disease progression unacceptable toxicity . After 2 month , patient stable respond disease may continue treatment . Patients achieve complete response ( CR ) continue treatment 8 month beyond CR . Tumors measure every 2 month 1 year every 3 month 1 year . PROJECTED ACCRUAL : Approximately 20-40 patient accrue study .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm cancer head neck unlikely respond exist therapy curative therapy exist Metastatic disease OR incurable surgery radiation Measurable disease CT scan MRI Tumor must least 2 cm lymph node locate head , neck , axillary , inguinal femoral area least 0.5 cm area PATIENT CHARACTERISTICS : Age : 16 Performance status : Karnofsky 60100 % Life expectancy : At least 2 month Hematopoietic : WBC least 2,000/mm^3 Platelet count least 50,000/mm^3 Hepatic : No hepatic insufficiency Bilirubin great 2.5 mg/dL SGOT SGPT great 2.5 mg/dL Renal : No renal insufficiency Creatinine great 2.5 mg/dL No renal condition contraindicate high dosage sodium Cardiovascular : No chronic heart failure No uncontrolled hypertension No history congestive heart failure No cardiovascular condition contraindicate high dosage sodium Pulmonary : No serious lung disease ( e.g. , severe chronic obstructive pulmonary disease ) Other : Not pregnant nursing Fertile patient must use effective contraception 4 week study participation No serious medical psychiatric condition No active infection PRIOR CONCURRENT THERAPY : Biologic therapy : At least 4 week since prior immunotherapy recover No concurrent immunomodulatory agent Chemotherapy : At least 4 week since prior chemotherapy ( 6 week nitrosoureas ) recover No concurrent antineoplastic therapy Endocrine therapy : Concurrent corticosteroid allow Radiotherapy : See Disease Characteristics At least 8 week since prior radiotherapy ( unless multiple tumor ) recover Surgery : See Disease Characteristics Other : Prior cytodifferentiating agent allow</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2004</verification_date>
	<keyword>stage IV salivary gland cancer</keyword>
	<keyword>recurrent salivary gland cancer</keyword>
	<keyword>recurrent lymphoepithelioma nasopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage IV lymphoepithelioma nasopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma nasopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma larynx</keyword>
	<keyword>recurrent verrucous carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
	<keyword>stage IV verrucous carcinoma larynx</keyword>
	<keyword>recurrent squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>recurrent squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>recurrent esthesioneuroblastoma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent invert papilloma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent midline lethal granuloma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV esthesioneuroblastoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV invert papilloma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV midline lethal granuloma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent lymphoepithelioma oropharynx</keyword>
	<keyword>recurrent squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV lymphoepithelioma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>recurrent verrucous carcinoma oral cavity</keyword>
	<keyword>stage IV verrucous carcinoma oral cavity</keyword>
	<keyword>recurrent adenoid cystic carcinoma oral cavity</keyword>
	<keyword>stage IV adenoid cystic carcinoma oral cavity</keyword>
	<keyword>recurrent mucoepidermoid carcinoma oral cavity</keyword>
	<keyword>stage IV mucoepidermoid carcinoma oral cavity</keyword>
	<keyword>recurrent basal cell carcinoma lip</keyword>
	<keyword>stage IV basal cell carcinoma lip</keyword>
</DOC>